Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Daily aspirin associated with lower risk of COPD flareup

Key clinical point: Daily aspirin may reduce the risk of COPD exacerbations.

Major finding: Daily aspirin use was associated with 22% reduction in the incidence of COPD exacerbations.

Study details: Observational cohort study of 1,698 patients with COPD.

Disclosures: The National Institutes of Health funded the study. Six authors declared advisory board positions, research support, and other funding from the pharmaceutical sector. One author was also a founder of a company commercializing lung image analysis software. No other conflicts of interest were declared.


Fawzy A et al. Chest. 2019 Mar;155(3):519-27. doi: 10.1016/j.chest.2018.11.028.